• 股價
  • 漲跌
  • 漲幅
  • 成交量
Insulet Corporation (NASDAQ:PODD) Q4 2023 Earnings Call Transcript February 22, 2024
Insulet Corporation beats earnings expectations. Reported EPS is $1.44, expectations were $0.67. Insulet Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see t
    Jereme Sylvain, EVP CFO of DexCom Inc (NASDAQ:DXCM), has sold 3,363 shares of the company on February 20, 2024, according to a recent SEC Filing. Over the past year, the insider has sold a total of 12,741 shares and has not made any purchases of the company's stock.
    Warning! GuruFocus has detected
      In this piece, we will look at the 15 best stocks for long-term growth. If you want to skip our introduction to the current drivers of stock market performance, then check out 5 Best Stocks For Long Term Growth.
      The stock market in 2024 is characterized by a notably optimistic and forward-looking 
        The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But when you pick a company that is really flourishing, you can make more than 100%. For example, the DexCom, Inc. (NASDAQ:DXCM) share price has soared 222% in the last half dec
          Investors looking for growth stocks that can make dramatic moves to the upside want to focus on the healthcare and finance sectors. These two stocks tumbled during the week ended Feb. 9 even though the Wall Street analysts who follow them closely think the opposite should be happening.
          The price t
            Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. The market rebounded in the fourth quarter as the S&P 500 Index rose 11.69%. Aristotle Atlantic’s Focus Growth strategy retur